title stringlengths 1 1.19k | keywords stringlengths 0 668 | concept stringlengths 0 909 | paragraph stringlengths 0 61.8k | PMID stringlengths 10 11 |
|---|---|---|---|---|
Radiostereometric analysis | fracture, fractures, Fracture | IMPACTION | Screw migration in the femoral head/neck was similar between the HA-coated group and the NON-coated group at 6 weeks, 3 months, and 6 months (Screw migration displayed as means in mm and degrees with 95% confidence intervals (CI 95%) at 6 weeks (Furthermore, there was no statistically significant difference between gro... | PMC10503211 |
RSA precision | For screw migration (A. Repeatability of screw migration with reference to the head/neck fracture segment given in the coordinate system of the EGS model of the screw as absolute values from RSA double-examinations (PI = Prediction interval of precision | PMC10503211 | ||
Discussion | fracture, fractures | EVANS, IMPACTION | Only few studies have assessed screw fixation and fracture migration in pertrochanteric fractures using RSA. The key-finding in this RSA study was similar and low migration of lag screws with HA-coated and NON-coated threads of a SHS in the femoral head/neck fragment in stable (Evans type I, II, IV) pertrochanteric hip... | PMC10503211 |
Screw migration | In general, HA has been shown to improve osseointegration and fixation with various orthopedic implants including screws [ | PMC10503211 | ||
Fracture stability | femoral neck fractures, pertrochanteric fractures, fracture, Fracture, fractures, non-union | In the treatment of pertrochanteric fractures a stable internal fixation accomplished with dynamic compression of the fracture sites is important to achieve stability and healing. Van Embden et al. described a mean shortening of 7.1 mm (range 4.6–10.7) after 6 weeks in 4 pertrochanteric fractures treated with a SHS [Th... | PMC10503211 | |
Clinical outcomes | At baseline this fragile patient group reported a pre-fracture mean HHS of 85 points, which was lower than the similar aged background population [ | PMC10503211 | ||
Strengths and limitations | fractures | The strength of this study lies in the double-blinded randomized controlled study design, the high precision of RSA as a validated method to measure migrations of both implants and fractures, and the protocolled similarity of the treatment algorithm in both inclusion sites [ | PMC10503211 | |
Conclusion | fracture, fractures | There was no clinical benefit of hydroxyapatite coating on SHS screw migration in this patient cohort, which may be explained by a good screw placement. Migration of the pertrochanteric fractures stabilized around 6 weeks follow-up and with acceptable fracture displacement and no mechanical failures. | PMC10503211 | |
Acknowledgements | LARSEN | The authors would like to thank project nurse Anne-Birgitte Larsen for her valued help with project coordination and Anne Dorthe Riedel for her valued help with project coordination and RSA analyses. | PMC10503211 | |
Author contributions | ACK contributed to image analysis, statistical analysis and data interpretation, writing of the original draft and manuscript revision. JKT performed statistical analyses and contributed to data interpretation, writing of the original draft and manuscript revision. TBH contributed to study planning, data collection and... | PMC10503211 | ||
Funding | Biomet supported the study financially but had no influence on the manuscript or publication. The authors of this study report no conflict of interest. | PMC10503211 | ||
Declarations | PMC10503211 | |||
Ethics approval and consent to participate | -11 | The study was approved by the Data Protection Agency (1-16-02-175-11) and the Central Denmark Regions Committee on Biomedical Research Ethics (M-20110224) and was carried out in agreement with the Helsinki II Declaration. | PMC10503211 | |
Competing interests | The authors declare no competing interests. | PMC10503211 | ||
References | PMC10503211 | |||
Purpose | endometriosis, pelvic pain, pain | ENDOMETRIOSIS | Despite standard medical treatment endometriosis is often associated with disabling pain and poor quality of life (QoL). Studies indicate that psychological interventions (PIs) may improve pain and QoL, yet studies on the effects of PIs for women with endometriosis are sparse and limited by low-quality study designs. T... | PMC10172241 |
Methods | endometriosis, pelvic pain, pain, endometriosis-related, WL, NRS | ENDOMETRIOSIS | This three-armed parallel, multi-center randomized controlled trial included fifty-eight endometriosis patients reporting severe CPP [≥ 5 for pain intensity measured on a 0–10-point numeric rating scale (NRS)]. Patients were randomly assigned to (1) Specific mindfulness- and acceptance-based psychological intervention ... | PMC10172241 |
Results | endometriosis-related, constipation, dyschezia’, pain | Compared to WL, psychological intervention (MY-ENDO + Non-specific) did not significantly reduce pain. However, psychological intervention did significantly improve the QoL-subscales ‘control and powerlessness’, ‘emotional well-being’, and ‘social support’ as well as the endometriosis-related symptoms ‘dyschezia’ and ‘... | PMC10172241 | |
Conclusions | endometriosis | ENDOMETRIOSIS | Women with endometriosis may have significant and large effects of psychological intervention on QoL despite an ongoing experience of severe CPP. | PMC10172241 |
Trial registration | 12 April 2016, clinicaltrials.gov (NCT02761382), retrospectively registered. | PMC10172241 | ||
Keywords | PMC10172241 | |||
Plain English summary | Endometriosis, endometriosis, pelvic pain, pain, constipation, endometriosis-related, chronic gynecological disease | ENDOMETRIOSIS, ENDOMETRIOSIS | Endometriosis is a chronic gynecological disease affecting 5–10% of women worldwide. It can lead to disabling pelvic pain and poor quality of life. The traditional treatments for painful endometriosis consist of medical and/or surgical treatment. However, these treatments are, in many cases, insufficient in relieving t... | PMC10172241 |
Background | Endometriosis, endometriosis, bleeding, gynecological disease, pain, endometrial lesions, chronic pain, WL, adhesions | ENDOMETRIOSIS, BLEEDING, ENDOMETRIOSIS, RECURRENCE, GYNECOLOGICAL DISEASE, INFLAMMATION, SECONDARY, CHRONIC PAIN, UTERUS, ADHESIONS | Endometriosis is a chronic and often painful gynecological disease defined as the presence and growth of endometrium-like tissue outside the uterus, usually in the pelvis, where it causes bleeding, inflammation, and adhesions [Current standard treatment for painful endometriosis includes hormonal treatment, pain medica... | PMC10172241 |
Methods | PMC10172241 | |||
Study design | WL, pain | Patients were randomly assigned to one of three conditions: (1) A specific mindfulness- and acceptance-based PI called “Mind Your ENDOmetriosis” (MY-ENDO), (2) A non-specific PI (Non-specific) that matched MY-ENDO in non-specific factors such as empathy, the therapeutic alliance, a cogent rationale, and expectations of... | PMC10172241 | |
Participants | endometriosis, MRI-confirmed endometriosis, Endometriosis, pain | ENDOMETRIOSIS, ENDOMETRIOSIS | Participants were recruited from three specialized outpatient clinics for endometriosis in Denmark and from the Danish Endometriosis Patients Association. All patients considered for inclusion underwent screening to assess in- and exclusion criteria. Inclusion criteria were: (a) 18–47 years old, (b) surgery or MRI-conf... | PMC10172241 |
Procedure | pain | A letter was sent to interested patients with study details and a pain diary to be filled out before the screening session. At the screening, patients were informed about study requirements and screened for in- and exclusion criteria. They provided written informed consent before enrolment in the study and randomizatio... | PMC10172241 | |
Interventions | PMC10172241 | |||
Non-specific | To properly test whether MY-ENDO was truly superior to other psychological interventions and if the effects were due to specific mindfulness ingredients, the control condition had to be an intervention based on psychological principles. This means: (1) to have a cogent and acceptable rationale (2) to include correspond... | PMC10172241 | ||
Waitlist | gynecological pain | The Wait-list group received medical treatment as usual and completed the same questionnaires and gynecological pain assessment as the intervention groups. | PMC10172241 | |
Therapists | Two private practicing clinical psychologists, both licensed by the Danish board of psychologists and closely matched on essential parameters (training, apprenticeship, and competence), were recruited to deliver the interventions in a “crossed-therapist” design, with both therapists providing both treatments within the... | PMC10172241 | ||
Study outcome measures | Along with a sociodemographic questionnaire, patients received the following questionnaires: | PMC10172241 | ||
Sample size | Pelvic pain, WL, pelvic pain | SECONDARY | Sample size was based on power analysis of a small randomized 3-armed pilot study (unpublished) for the primary outcome of pelvic pain between the groups: (1) PI vs. WL and (2) MY-ENDO vs. Non-specific and for the secondary outcome of QoL between the groups PI vs. WL. Pelvic pain was measured on NRS. The NRS scale scor... | PMC10172241 |
Statistical analysis | Baseline group differences were compared by the | PMC10172241 | ||
Results | PMC10172241 | |||
MY-ENDO vs. non-specific | pelvic pain, diarrhea | SECONDARY | Statistically significant time × group effects were found for pelvic pain intensity (Neither did we find any statistically significant time × group interactions for the secondary outcomes except for diarrhea (With regards to the time spent on home practice, we did not find a significant difference between MY-ENDO (Mean... | PMC10172241 |
Post-hoc analyses | pelvic pain, pain | When dividing participants into two groups (taking vs. not taking pain medication) independent of randomization allocation, statistically significant time × group effects were found for pelvic pain intensity (F = 11.3, Differences in pelvic pain between the groups “taking pain medication” vs. “not taking pain medicatio... | PMC10172241 | |
Discussion | endometriosis, pelvic pain, constipation, pain, endometriosis-related, chronic pain | CHRONIC PAIN, ENDOMETRIOSIS | In this rigorous three-armed design we have demonstrated that psychological intervention (PI) does not significantly reduce pelvic pain in women suffering from endometriosis. Instead, PI led to large and significant improvements in QoL despite an ongoing experience of severe CPP.Cochrane meta-analyses of psychological ... | PMC10172241 |
Strengths and limitations | fatigue, pain | STILL | Notably, this study has some strengths that are rarely seen in RCTs examining the effects of psychological interventions. The inclusion of a carefully matched non-specific control condition and a no-treatment control in a 3-armed RCT together with the attempt to reduce significant threats to internal validity (e.g., ba... | PMC10172241 |
Author contributions | RP | KEH coordinated the project KEH, BB, LV, MK, RP, AF and USK conceived and designed the study. KEH, BB, MK, RP, OD and DH executed the study and KEH obtained the data. KEH, USK AF and LV analyzed and interpreted the data. KEH drafted the manuscript and BB, MK, AF, RP, OD, DH, USK and LV critically revised the manuscript... | PMC10172241 | |
Funding | Endometriosis | ENDOMETRIOSIS, ENDOMETRIOSIS | This work was supported by a donation from TrygFonden, a donation from Ladywalk, and a donation from the Danish Endometriosis Patient Association, a non-governmental organization run by women with endometriosis. | PMC10172241 |
Data availability | Data from this study is not publicly available due to restrictions pertaining to the general data protection regulation in Denmark but will be shared on reasonable request to the corresponding author. | PMC10172241 | ||
Declarations | PMC10172241 | |||
Competing interests | The authors declare that they have no competing interests. | PMC10172241 | ||
Ethical approval | The study was preregistered with The Danish Data Protection Agency (journal no. 2015-57-0002) and approved by The Central Denmark Region Committees on Health Research Ethics (registration no. 1-10-72-138-15). | PMC10172241 | ||
Consent to participate | All patients were informed about study requirements and provided written informed consent before enrolment in the study. | PMC10172241 | ||
References | PMC10172241 | |||
Methods | asphyxia, weight loss, illness, infection | BLOOD GROUP INCOMPATIBILITY, ASPHYXIA, INFECTION | This study included newborn infants who were part of a multicenter randomized trial conducted from August 2016 to September 2019. The ethical review board in Uppsala, Sweden, approved the study (D 2015/226) and it was registered at clinicaltrials.gov 24/05/2018 (NCT03536078). The original dataset included 147 patients ... | PMC10317991 |
Health economic evaluation method | In a cost-effectiveness analysis, the result is traditionally presented in terms of the incremental cost-effectiveness ratio (ICER). For the strategies being compared or evaluated, the ICER estimates the difference in costs (measured in monetary units) divided by the difference in effects, thus expressing the cost of a... | PMC10317991 | ||
Data on costs | Recently updated standards recommend that health economic evaluations present results from both a societal and a health care perspectiveTime and materials costs were based on actual resource use as registered in the study and monetarily valued mainly based on regional price tariffs. Details are presented in Table Unit ... | PMC10317991 | ||
Ethics approval | This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the regional ethical review board in Uppsala, Sweden (2015/336). | PMC10317991 | ||
Consent to participate | Written informed consent was obtained from the parents. | PMC10317991 | ||
Consent for publication | Written informed consent was obtained from the parents. | PMC10317991 | ||
Sensitivity analysis | In the sensitivity analysis by bootstrapping, all 1000 drawings showed home phototherapy as the cost-saving alternative, with savings ranging from €483 to €1152 when hospital treatment was offered at the maternity unit.For treatment duration, 40% of the drawings showed home phototherapy as the more effective, i.e. havi... | PMC10317991 | ||
Author contributions | M.P., M.E. and A.O. all contributed to the study conception and design. Material preparation and data collection was performed by M.P., M.E., and A.O. Analysis was performed by M.P., M.E., A.O. and L.R. The first draft of the manuscript was written by A.O. and all authors commented on previous versions of the manuscrip... | PMC10317991 | ||
Funding | Open access funding provided by Örebro University. This study was funded by the Uppsala and Örebro regional county council. | PMC10317991 | ||
Data availability | The datasets used and/or analysed during the current study available from the corresponding author on reasonable request. | PMC10317991 | ||
Competing interests | The authors declare no competing interests. | PMC10317991 | ||
References | PMC10317991 | |||
1. Introduction | cancers | CHRONIC INFLAMMATION, CANCERS, TUMOUR NECROSIS, CHRONIC DISEASES, ADHESION, CHRONIC INFLAMMATION, INFLAMMATORY RESPONSE | Increasing evidence supports that a higher dietary inflammatory index (DIIThe inflammatory response involves the production of a range of pro-inflammatory biomarkers including cytokines, interleukins (IL), adhesion molecules, tumour necrosis factor, and high sensitivity C-reactive protein (hsCRP) as part of the body’s ... | PMC9866776 |
2. Methods | The MedLey study was a dietitian-led, randomized, controlled, parallel dietary intervention trial comparing the effect of a traditional MedDiet with a habitual diet on cognitive and cardiometabolic health outcomes in a healthy elderly population. The protocol has been described elsewhere [ | PMC9866776 | ||
2.1. Calculating the DII and E-DII Scores | The DII was developed to estimate the inflammatory potential of an overall food pattern and has been described elsewhere [Food-specific parameters used to calculate the DII that were available from the MedLey study WFR include energy (kJ), carbohydrate (CHO, g), protein (g), total fat (g), monounsaturated fat (MUFA, g)... | PMC9866776 | ||
2.2. Statistical Analysis | Statistical analyses were performed using SPSS version 21.0 (SPSS Inc., Chicago, IL, USA).Descriptive statistics were presented as mean ± SD with outcome variables reported as mean ± SEM. Statistical significance was set at | PMC9866776 | ||
2.2.1. Statistical Analysis of Changes in DII and E-DII Scores with Dietary Intervention | The effects of dietary interventions on the DII | PMC9866776 | ||
2.2.2. Statistical Analysis of Intervention Impacts Relating to DII and E-DII Scores | Results from the MedLey study showed significant improvements to cardiovascular risk factors. To assess if there was an association of the change in DII | PMC9866776 | ||
2.2.3. Statistical Analysis of Cross-Sectional Relationships of DII | INSULIN RESISTANCE, ADIPOSITY | Baseline data were examined irrespective of dietary intervention group to determine relationships between DII and body composition (BMI, weight, WHR, and abdominal adiposity), cardiometabolic health (hsCRP, blood cholesterol levels, homeostatic model of insulin resistance (HOMA)), and vascular health (blood pressure, f... | PMC9866776 | |
3. Results | Baseline characteristics of the MedLey population are published elsewhere [ | PMC9866776 | ||
3.1. Dietary Adherence to a MedDiet | Adherence to a MedDiet was calculated using a 15-point adherence score based on the methodology of Trichopoulou [ | PMC9866776 | ||
3.2. Dietary Inflammatory Index | There was no significant difference in the DII score at baseline between the MedDiet and HabDiet groups ( | PMC9866776 | ||
3.3. Cardiometabolic Health Outcomes of the MedLey Trial | Data from the MedLey study has been published elsewhere in detail [ | PMC9866776 | ||
3.4. Relationship of DII | overweight | There was no association found between the changes in cardiometabolic outcomes and the changes in DII, and these results did not change when the population was split into normal weight and overweight categories. We then explored if BP status at baseline may influence cardiometabolic outcomes and divided the data into “... | PMC9866776 | |
3.5. Cross-Sectional Relationships of DII | BLOOD | As there was no relationship between the change in cardiometabolic health outcomes of the dietary intervention and DII, baseline data from both groups were combined to explore relationships between DII status and cardiometabolic parameters. DII tertiles were established; the most anti-inflammatory dietary pattern (tert... | PMC9866776 | |
4. Discussion | obesity | OBESITY, EVENTS, ADIPOSITY, CVD | In this randomised dietary intervention trial, we demonstrated that high adherence to a MedDiet over 6 months led to improved DII/E-DII scores and anti-inflammatory activity compared to the HabDiet group in an older Australian cohort. However, no associations between DII/E-DII and cardiometabolic risk factors were foun... | PMC9866776 |
5. Conclusions | inflammation, cognitive and cardiovascular health | CVD, INFLAMMATION | Our results provide further evidence regarding the relationship between the dietary inflammatory index of a MedDiet and cardiometabolic outcomes. We demonstrated that high adherence to a MedDiet intervention over 6 months significantly lowered mean DII compared to a HabDiet in older Australians. The reduction of the in... | PMC9866776 |
Author Contributions | Conceptualization, K.J.M., K.A.D., N.S. and J.R.H.; methodology; K.J.M., C.R.D., N.S. and J.M.H.; investigation; K.A.D., C.R.D. and K.J.M.; data curation, R.W., K.A.D., K.J.M. and J.S.C.; writing—original draft preparation, K.A.D. and J.S.C.; writing—review and editing; K.J.M., K.A.D., C.R.D., N.S., J.R.H., J.M.H., R.W... | PMC9866776 | ||
Institutional Review Board Statement | MAY | This study was conducted in accordance with the Declaration of Helsinki, and approved by the University of South Australian Ethics Committee, protocol code (#31163) on the 22 June 2013. The trial was registered with the Australia New Zealand Clinical Trials Register (ACTRN12613000602729), on the 27 May 2013. | PMC9866776 | |
Informed Consent Statement | Written informed consent was obtained from all participants before commencement. | PMC9866776 | ||
Data Availability Statement | Data from the MedLey study contains sensitive participant information. For data access, please contact the University of South Australia Human Research Ethics Committee | PMC9866776 | ||
Conflicts of Interest | The authors declare no conflict of interest. | PMC9866776 | ||
Abbreviations | CVD, CARDIOVASCULAR DISEASE | BMI, body mass index; BP, blood pressure; CHO, carbohydrate; hsCRP, high sensitivity C-reactive protein; CVD, cardiovascular disease; DBP, diastolic blood pressure; DII, dietary inflammatory index; F | PMC9866776 | |
References | adiposity | ADIPOSITY | Changes in the dietary inflammatory index during the MedLey intervention: (Baseline dietary inflammatory index (adjusted for energy intake) stratified into tertiles. Tertile 1 represents the lowest E-DII, being the most anti-inflammatory, while tertile 3 represents the highest E-DII, being the most pro-inflammatory.Ter... | PMC9866776 |
Methods | Hepatitis B | REGRESSION, HEPATITIS B, NAIROBI | We conducted a cross sectional analysis of data collected from individuals who were screened in Kenya (Nairobi) and Uganda (Entebbe and Kampala). The studies followed hypothetical procedures of an HIV vaccine efficacy trial and aimed to enroll HIV negative key and vulnerable populations at elevated risk of HIV acquisit... | PMC10351693 |
Results | acute infection, chronic infection, HBV infection, infection, HBV infected | ACUTE INFECTION, CHRONIC INFECTION, NAIROBI, INFECTION, SECONDARY | We screened 1,366 participants with mean age (SD) 28.7 (7.3) years. Overall, 46.6% were from Entebbe, 50.7% had secondary or higher level of education, 76.4% had informal high-risk jobs and 56.3% were male. Kampala had only female participants contributing 60.6% of females screened. Of the screened participants, 94.7% ... | PMC10351693 |
Conclusion | HIV vaccine, low among HIV negative, HBV infection | HBV prevalence and immunity due to vaccination were low among HIV negative individuals who are eligible for HIV vaccine trials and prevalence varies by age, education level and main occupation. Younger individuals and those recruited from existing cohorts/ clinics have a higher likelihood of having no prior HBV infecti... | PMC10351693 | |
Data Availability | All relevant data are within the manuscript and its | PMC10351693 | ||
Introduction | hepatitis B, Simulated HIV vaccine, liver cirrhosis, primary liver cancer, KPs living with HIV show varied HBV | HEPATITIS B, VIRUS, CHRONIC INFECTION, LIVER CIRRHOSIS, PRIMARY LIVER CANCER | Worldwide in 2019, an estimated 1.5 million people acquired hepatitis B virus (HBV), a chronic infection of public health concern because it is complicated by liver cirrhosis and primary liver cancer in 20–30% of individuals [Recent surveys done among KPs living with HIV show varied HBV prevalence, including 4.0% from ... | PMC10351693 |
Materials and methods | PMC10351693 | |||
Study design | We conducted a cross sectional analysis of data collected from individuals who were screened for SiVET studies at three sites: two in Uganda and one in Kenya. | PMC10351693 | ||
Study populations | RECRUITMENT, NAIROBI | All three SiVETs, following the hypothetical procedures of an HIV vaccine efficacy trial, aimed to enroll key and vulnerable populations at elevated risk of HIV acquisition. Each site followed a similar visit schedule and study procedures but focused on different populations based on site experience and expertise. The ... | PMC10351693 | |
Study settings and sampling | PMC10351693 | |||
Entebbe site | AIDS | AIDS | The Uganda Virus Research Institute/ International AIDS Vaccine Initiative (UVRI-IAVI) HIV vaccine program conducted the study in two conveniently selected fishing communities (FCs) on Lake Victoria, one island and one on the mainland. Volunteers were randomly selected from the two FCs. Screening was conducted from Dec... | PMC10351693 |
Kampala site | The study was conducted at the Good Health for Women Project (GHWP) clinic of the Medical Research Council/ Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit. The clinic was in a peri-urban community in southern Kampala and enrolled and followed... | PMC10351693 | ||
Nairobi site | NAIROBI | The KAVI- Institute for Clinical Research (KAVI-ICR), conducted the study at the college of health sciences, University of Nairobi. KAVI-ICR set enrollment numbers at 80% MSM, 20% FSWs. Screening was conducted from the Sex Workers Outreach Program (SWOP-Kenya) clinics in Nairobi from September 2015 to September 2017 an... | PMC10351693 | |
Eligibility and screening procedures | Hepatitis B infection | HEPATITIS B INFECTION, NAIROBI | Potential volunteers were invited for SiVET study screening if they had been community residents in the FCs for at least 6 months (Entebbe), had been attending the GHWP clinic for 6 to 18 months and had tested HIV negative at the last clinic visit (Kampala) or had been enrolled for at least 6 months in the SWOP network... | PMC10351693 |
Laboratory procedures | infection | HEPATITIS B, HEPATITIS B, INFECTION | HIV testing was performed on serum using two or more rapid antibody diagnostic tests administered serially (Entebbe and Kampala) as follows: Determine screening test (Alere DetermineAll sites measured hepatitis B surface antigen (HBsAg) and total hepatitis B core antibody (HBcAb (Total)). The site in Kampala also measu... | PMC10351693 |
Assays used by participating research centers to screen for Hepatitis B. | PMC10351693 | |||
Statistical analysis | Data analyses were conducted using STATA version 16.0 (Stata Corporation, College Station, Texas, USA) and R version 4.2.1 ( | PMC10351693 | ||
Ethical considerations | NAIROBI | The Uganda National Council for Science and Technology (HS 1850, HS 1584) and Uganda Virus Research Institute-Research Ethics Committee (GC/127/15/07/439, GC/127/14/04/454) approved the Entebbe and Kampala SiVET studies, respectively. The Nairobi SiVET was approved by Kenyatta National Hospital/University of Nairobi Et... | PMC10351693 | |
Results | PMC10351693 | |||
Socio-demographic characteristics of participants screened for SiVET studies in Kenya and Uganda (2014–2017) | As shown in | PMC10351693 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.